Definitive Contract 75F40122C00195

The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...

The U.S. Food and Drug Administration (FDA) awarded a $262,548.81 firm fixed-price contract to the South Dakota Department of Health (SD DOH) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). This contract, awarded on June 30, 2022, has an ultimate completion date of January 1, 2028. The contract was issued as a sole-source award, as the state government organization is the...

This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...

The Food and Drug Administration (FDA) awarded a $483,881.81 firm-fixed-price definitive contract to the Arkansas Department of Health (ADH) for the "ARKANSAS MQSA INSPECTION CONTRACT". This contract supports inspections of certified non-federal mammography facilities in Arkansas to ensure compliance with the Mammography Quality Standards Act (MQSA). ADH was selected as the sole source provider for this requirement due to its legal authority under state law to access commercial...

This federal contract award, with ID 223044452, was issued by the Food and Drug Administration (FDA), a civilian government agency, to the City of New York through its Department of Health and Mental Hygiene (New York City Health Department). The contract, a definitive, firm-fixed-price contract with a ceiling value of $245,598.69, has a period of performance running from September 1, 2004 to August 31, 2005. There was no set-aside designation for this contract. The contract appears to be for...

<p>The U.S. Food and Drug Administration (FDA) awarded a $359,633.67 firm fixed price definitive contract to the Alaska Division of Public Health for ALASKA MQSA STATE INSPECTIONS. The contract has an ultimate completion date of March 4, 2028. There is no set-aside designation for this award. The contract requires the Alaska Division of Public Health to provide MQSA state inspections services in Anchorage, Alaska.</p>

The Food and Drug Administration (FDA) awarded a $236,714.59, firm fixed price definitive contract to the New Hampshire Department of Health and Human Services (NH DHHS) to perform inspections of certified non-federal mammography facilities in New Hampshire. This contract, which runs through March 31, 2028, is to ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract was not set aside and was competitively awarded to the state agency, which...

This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the Massachusetts Department of Public Health, a U.S. state government entity, for Mass MQSA (Mammography Quality Standards Act) inspections. The contract has a firm fixed price pricing type and a potential value of $1,711,136.29. It was awarded on June 1, 2017 with a completion date of June 30, 2022. This contract is not associated with a larger vehicle and does not have a...

This contract was awarded by the Food and Drug Administration (FDA) to the Arizona Department of Health Services (ADHS), a state government entity, to conduct inspections of certified non-federal mammography facilities in Arizona. The contract, valued at $1,911,936.08, is a definitive, firm-fixed-price contract with a period of performance through March 29, 2028. The original solicitation was a sole-source procurement, as the inspections require legal authority under state law and experience...

This is a $2,685,565.01 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH) for Massachusetts MQSA (Mammography Quality Standards Act) new contract services. The contract has no set-aside designation and an ultimate completion date of January 21, 2028. MDPH, a U.S. state government agency, is the prime contractor and will provide specialized public health services to the FDA, including food and tobacco...